We are in the process of getting funding for the pharmacokinetics evaluation, and to make 6-hour/12-hour release pills. Then we are going to start the first FDA trails. In order to help millions of individuals around the world. 

We have Just obtained a provisional patent on the discovery of the first ever pharmaceutical drug therapy for autism. The chemical compound  helps the main symptoms of social and cognition function can be contributed to the neuro-brain structure. The Neurexin-1 beta gene mutations and cause a shortage in the prefrontal and orbital part which causes anti-social activities such as Autism, Anti-social Disorder, and social anxiety. Neurexins exhibit inhibitory and excitatory in the peripheral and central nervous system in the control of body functions in the synapses. The chemical combination helps revert the mutation and helps increase social cognition. Testing  on a small scale has backed up our statement and is very promising.